  See all
 |
Articles: General Pharma |
|
Receive free subspecialty "5-minute updates" via email
|
US FDA approves new indication for CRESTOR
AstraZeneca, 02/09/10
Free full text
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Abbott, 02/09/10 Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regions
Teva Pharmaceutical Industries, 02/09/10
Free full text
Teva acquires marketing rights for oral laquinimod in the nordic and baltic regions
Active Biotech, 02/09/10
Free full text
Synthon announces European approvals for Raloxifene
Synthon, 02/09/10
Free full text
Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
Amgen, 02/09/10
Free full text
New Members Join eHealths Board
HealthDataManagement, 02/09/10 Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone
Nabi Biopharmaceuticals, 02/09/10
Free full text
FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
The Oncologist, 02/09/10
Free full text
Comment Sought on Cancer Trials Database
HealthDataManagement, 02/09/10 Blood Mgmt. Firm to Buy Global Med
HealthDataManagement, 02/09/10 Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2009 Financial Results on February
Cell Therapeutics, 02/09/10
Free full text
Medtronic Donates Medical Supplies to Haiti Relief Effort
Medtronic, 02/09/10
Free full text
Prior Articles
Study Suggests Slide-On Endosheath System Provides Several Advantages Over Traditional Germicidal Immersion
Medtronic, 02/08/10
Free full text
Lundbeck appoints Vice President of Investor Relations and Communications
Lundbeck, 02/08/10
Free full text
Protox Announces Private Placement
Protox Therapeutics, 02/08/10
Free full text
Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits
Teva Pharmaceutical Industries, 02/08/10
Free full text
Effectiveness and Safety of Proton Pump Inhibitors in Infantile Gastroesophageal Reflux Disease
Annals of Pharmacotherapy, 02/08/10 AVI BioPharmas Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrophy
AVI BioPharma, 02/08/10
Free full text
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
Clinical Pharmacology & Therapeutics, 02/08/10
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
125 Available Pages
|
|
